Adial Pharmaceuticals Inc (ADIL)

Currency in USD
1.720
-0.110(-6.01%)
Closed·
1.670-0.050(-2.91%)
·
Trading near 52-week Low
ADIL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5401.810
52 wk Range
1.54030.250
Key Statistics
Prev. Close
1.72
Open
1.79
Day's Range
1.54-1.81
52 wk Range
1.54-30.25
Volume
124.18K
Average Volume (3m)
69.24K
1-Year Change
-90.4444%
Book Value / Share
4.95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADIL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.333
Upside
+1,256.59%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Adial Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.

Compare ADIL to Peers and Sector

Metrics to compare
ADIL
Peers
Sector
Relationship
P/E Ratio
−0.3x−1.0x−0.5x
PEG Ratio
0.00−0.060.00
Price/Book
0.5x1.1x2.6x
Price / LTM Sales
-1.9x3.2x
Upside (Analyst Target)
-174.1%51.4%
Fair Value Upside
Unlock13.5%7.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 23.333
(+1,256.59% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy8.00+365.12%37.50MaintainFeb 11, 2026
Maxim Group
Buy1.50-12.79%-UpgradeSep 30, 2025
Brookline Capital Markets
Buy2.00+16.28%4.00MaintainJun 26, 2025

Earnings

Latest Release
Mar 05, 2026
EPS / Forecast
-1.82 / -0.39
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ADIL Income Statement

People Also Watch

1.7200
BHAT
-1.15%
2.730
HCTI
+1.11%
0.646
OCG
-1.37%
8.68
VNDA
+10.01%
0.05
ELPW
0.00%

FAQ

What Is the Adial Pharma (ADIL) Stock Price Today?

The Adial Pharma stock price today is 1.720 USD.

What Stock Exchange Does Adial Pharma Trade On?

Adial Pharma is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Adial Pharma?

The stock symbol for Adial Pharma is "ADIL."

What Is the Adial Pharma Market Cap?

As of today, Adial Pharma market cap is 2.460M USD.

What Is Adial Pharma's Earnings Per Share (TTM)?

The Adial Pharma EPS (TTM) is -11.930.

From a Technical Analysis Perspective, Is ADIL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Adial Pharma Stock Split?

Adial Pharma has split 2 times.

How Many Employees Does Adial Pharma Have?

Adial Pharma has 5 employees.

What is the current trading status of Adial Pharma (ADIL)?

As of Mar 10, 2026, Adial Pharma (ADIL) is trading at a price of 1.720 USD, with a previous close of 1.720 USD. The stock has fluctuated within a day range of 1.540 USD to 1.810 USD, while its 52-week range spans from 1.540 USD to 30.250 USD.

What Is Adial Pharma (ADIL) Price Target According to Analysts?

The average 12-month price target for Adial Pharma is 23.333 USD, with a high estimate of 42 USD and a low estimate of 8 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,256.59% Upside potential.

What Is the ADIL After Hours Price?

ADIL's last after hours stock price is 1.670 USD, the stock has decreased by -0.050, or -2.910%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.